These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9694743)

  • 21. Resistance to activated protein C: a major cause of inherited thrombophilia.
    Jensen R; Ens GE
    Clin Lab Sci; 1997; 10(4):219-22. PubMed ID: 10169621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resistance to activated protein C due to mutated factor V as a novel cause of inherited thrombophilia.
    De Stefano V; Leone G
    Haematologica; 1995; 80(4):344-56. PubMed ID: 7590506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. "Pseudo homozygous" activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type I quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindreds.
    Simioni P; Scudeller A; Radossi P; Gavasso S; Girolami B; Tormene D; Girolami A
    Thromb Haemost; 1996 Mar; 75(3):422-6. PubMed ID: 8701401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenprocoumon-induced hepatitis delaying precise diagnosis in a thrombophilic patient with activated protein C resistance due to factor V R506Q mutation.
    Wuillemin WA; Zenhäusern R; Bernhard MC; Lämmle B
    Am J Med; 1997 Nov; 103(5):437-9. PubMed ID: 9375713
    [No Abstract]   [Full Text] [Related]  

  • 25. Homozygous APC-resistance combined with inherited type I protein S deficiency in a young boy with severe thrombotic disease.
    Zöller B; He X; Dahlbäck B
    Thromb Haemost; 1995 May; 73(5):743-5. PubMed ID: 7482396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment.
    Salomon O; Steinberg DM; Zivelin A; Gitel S; Dardik R; Rosenberg N; Berliner S; Inbal A; Many A; Lubetsky A; Varon D; Martinowitz U; Seligsohn U
    Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):511-8. PubMed ID: 10073951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Venous thromboembolism associated with double heterozygosity for R506Q mutation of factor V and for T298M mutation of protein C in a large family of a previously described homozygous protein C-deficient newborn with massive thrombosis.
    Brenner B; Zivelin A; Lanir N; Greengard JS; Griffin JH; Seligsohn U
    Blood; 1996 Aug; 88(3):877-80. PubMed ID: 8704244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New molecular insights into the genetics of thrombophilia. Resistance to activated protein C caused by Arg506 to Gln mutation in factor V as a pathogenic risk factor for venous thrombosis.
    Dahlbäck B
    Thromb Haemost; 1995 Jul; 74(1):139-48. PubMed ID: 8578447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. APC resistance in an elite female athlete.
    Hilberg T; Moessmer G; Hartard M; Jeschke D
    Med Sci Sports Exerc; 1998 Feb; 30(2):183-4. PubMed ID: 9502342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and laboratory expression of associated thrombophilic conditions (homozygous/heterozygous factor V Leiden mutation and heterozygous prothrombin variant 20210A) in an Italian family.
    Simioni P; Tormene D; Luni S; Caldato M; Girolami A
    Blood Coagul Fibrinolysis; 2000 Jun; 11(4):379-84. PubMed ID: 10847426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The G1691A mutation of the coagulation factor V gene (factor V Leiden) is rare in Chinese: an analysis of 618 individuals.
    Ko YL; Hsu TS; Wu SM; Ko YS; Chang CJ; Wang SM; Chen WJ; Cheng NJ; Kuo CT; Chiang CW; Lee YS
    Hum Genet; 1996 Aug; 98(2):176-7. PubMed ID: 8698336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discrimination between normal wildtype and carriers of coagulation factor V Leiden mutation by the activated protein C resistance test in the presence of factor V deficient plasma.
    Reuner KH; Litfin F; Patscheke H
    Eur J Clin Chem Clin Biochem; 1997 Jan; 35(1):41-5. PubMed ID: 9156566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Idiopathic Budd-Chiari syndrome in a patient with homozygous Factor V Leiden and heterozygous Factor II G20210A mutations.
    De Stefano V; Madonna P; Giannino A; Coppola A; Cerbone AM; Pauciullo P; Di Minno G
    Thromb Res; 2000 Dec; 100(6):567-8. PubMed ID: 11197916
    [No Abstract]   [Full Text] [Related]  

  • 34. Alternative PCR method for diagnosis of mutation causing activated protein C resistant Gln506-factor V.
    Greengard JS; Xu X; Gandrille S; Griffin JH
    Thromb Res; 1995 Dec; 80(5):441-3. PubMed ID: 8588206
    [No Abstract]   [Full Text] [Related]  

  • 35. The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis.
    de Visser MC; Guasch JF; Kamphuisen PW; Vos HL; Rosendaal FR; Bertina RM
    Thromb Haemost; 2000 Apr; 83(4):577-82. PubMed ID: 10780320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resistance to activated protein C caused by the factor VR506Q mutation is a common risk factor for venous thrombosis.
    Dahlbäck B
    Thromb Haemost; 1997 Jul; 78(1):483-8. PubMed ID: 9198201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factor II 20210 G-->A polymorphism associated to factor V Leiden: a report of two thrombophilic families.
    Prisco D; Gori AM; Pepe G; Marcucci R; Brunelli T; Giusti B; Gensini GF; Abbate R
    Thromb Res; 1998 Mar; 89(5):249-52. PubMed ID: 9645919
    [No Abstract]   [Full Text] [Related]  

  • 38. A novel mutation in intron K of the PROS1 gene causes aberrant RNA splicing and is a common cause of protein S deficiency in a UK thrombophilia cohort.
    Beauchamp NJ; Daly ME; Makris M; Preston FE; Peake IR
    Thromb Haemost; 1998 Jun; 79(6):1086-91. PubMed ID: 9657428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The factor V Leiden mutation: spectrum of thrombotic events and laboratory evaluation.
    Bontempo FA; Hassett AC; Faruki H; Steed DL; Webster MW; Makaroun MS
    J Vasc Surg; 1997 Feb; 25(2):271-5; discussion 276. PubMed ID: 9052561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strikes in French public transport and resistance to activated protein C.
    Eschwège V; Robert A
    Lancet; 1996 Jan; 347(8995):206. PubMed ID: 8544587
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.